NIH Small Business Workshop for Faculty/Postdocs
Time & Date: 8 a.m. – 5:30 p.m. on September 7, 2016 & 8:30 a.m. – 4 p.m. on September 8, 2016
Location: UTSA Main Campus, JPL Assembly Room (4.04.22)
The UT Health Science Center and UTSA are co-hosting an NIH Multi-IC (NIAID/NCI/NIGMS/NIBIB) Small Business Workshop providing an overview of NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) program.
The two-day workshop will cover topics on NIH scientific review, high priority areas of interest, writing a competitive SBIR/STTR application, how to pitch your business to investors, and unique career opportunities in biomedical entrepreneurship and commercialization.
Register Online at http://1.usa.gov/1YuGGJG
Annual Conference for Community Engagement and Healthcare Improvement
Date: September 2 - 4, 2016
Location: Wyndham San Antonio Riverwalk
Agenda & Registration
Ms. Patrick-Lake, Interim Director of Participant Engagement for the NIH Precision Medicine Initiative Cohort Program is the keynote speaker at CEHI. Her presentation will be interactive and will address precision medicine, stakeholder engagement, and improving health outcomes.
Science, Technology & Innovation Reception, STIR presents:
"DNA Repair Profiling Reveals Nonrandom Outcomes at Cas9-Mediated Breaks" a technical science presentation for faculty, trainees and students.
Time: 1 p.m. - 2 p.m.
Date: September 28, 2016
Location: MARC Buildig, Conference Rm. B, 8300 Floyd Curl Dr.
"Career editing: A CRISPR journey from academia to industry"
Time: 5:30 p.m. - 7:30 p.m.
Date: September 28, 2016
Location: Greehey Children's Cancer Resarch Institute, 8403 Floyd Curl Dr.
The Office of Technology Commercialization will host a reception open to the local research and life sciences community interested in collaborating on the commercialization of Health Science Center technologies.
Guest speaker, Rachel Haurwitz, Ph.D., Co-founder, President and CEO of Caribou Biosciences, will share her story of innovation and entrepreneurship, covering multiple CRISPR-derived technologies which have applications in genome engineering.
She has a research background in CRISPR-Cas biology, and in 2014, she was named by Forbes Magazine to the "30 Under 30" list in Science and Healthcare. She is also a co-founder of Intellia Therapeutics where she is a member of the board of directors. Haurwitz is an inventor on several patents and patent applications covering multiple CRISPR-derived technologies, and she has co-authored scientific papers in high impact journals characterizing CRISPR-Cas systems. She earned an A.B. in Biological Sciences from Harvard College, and received a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley.
Society of General Physiologists 70th Annual Meeting & Symposium presents: "Genetic & animal Models for Ion Channel Function in Physiology and Disease"
Marine Biological Laboratory, Woods Hole, MA, September 7 - 8, 2016. For details visit www.sgpweb.org